{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:01:19Z","timestamp":1789585279765,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG064859"],"award-info":[{"award-number":["RF1AG064859"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T32AG057461"],"award-info":[{"award-number":["T32AG057461"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T32AG078110"],"award-info":[{"award-number":["T32AG078110"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG043415"],"award-info":[{"award-number":["U01AG043415"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, &amp; Immunity - Health"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bbih.2024.100826","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T21:21:50Z","timestamp":1721769710000},"page":"100826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["A small molecule p38\u03b1 MAPK inhibitor, MW150, attenuates behavioral deficits and neuronal dysfunction in a mouse model of mixed amyloid and vascular pathologies"],"prefix":"10.1016","volume":"40","author":[{"given":"Hilaree N.","family":"Frazier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb S.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meggie J.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verda A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Dundon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"McLouth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana C.","family":"Muzyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin B.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saktimayee M.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8139-6400","authenticated-orcid":false,"given":"Linda J.","family":"Van Eldik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbih.2024.100826_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3233\/JAD-150277","article-title":"Selective brain-targeted antagonism of p38 MAPKalpha reduces hippocampal IL-1beta levels and improves Morris water maze performance in aged rats","volume":"48","author":"Alam","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.bbih.2024.100826_bib2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/jnc.13667","article-title":"Targeting innate immunity for neurodegenerative disorders of the central nervous system","volume":"138","author":"Andreasson","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbih.2024.100826_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.570586","article-title":"Functions of p38 MAP kinases in the central nervous system","volume":"13","author":"Asih","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.bbih.2024.100826_bib4","first-page":"199","article-title":"The p38 MAP kinase family as regulators of proinflammatory cytokine production in degenerative diseases of the CNS","volume":"1","author":"Bachstetter","year":"2010","journal-title":"Aging Dis"},{"key":"10.1016\/j.bbih.2024.100826_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1742-2094-8-79","article-title":"Microglial p38alpha MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Abeta)","volume":"8","author":"Bachstetter","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bbih.2024.100826_bib6","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1038\/s41467-021-22624-z","article-title":"Generation of a humanized Abeta expressing mouse demonstrating aspects of Alzheimer's disease-like pathology","volume":"12","author":"Baglietto-Vargas","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbih.2024.100826_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1098-1128(200103)21:2<129::AID-MED1003>3.0.CO;2-H","article-title":"Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia","volume":"21","author":"Barone","year":"2001","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbih.2024.100826_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/1759091419865788","article-title":"Blood flow deficits and cerebrovascular changes in a dietary model of hyperhomocysteinemia","volume":"11","author":"Braun","year":"2019","journal-title":"ASN Neuro"},{"issue":"1","key":"10.1016\/j.bbih.2024.100826_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262474","article-title":"Therapeutic treatment with the anti-inflammatory drug candidate MW151 may partially reduce memory impairment and normalizes hippocampal metabolic markers in a mouse model of comorbid amyloid and vascular pathology","volume":"17","author":"Braun","year":"2022","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbih.2024.100826_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286495","article-title":"Early chronic suppression of microglial p38alpha in a model of Alzheimer's disease does not significantly alter amyloid-associated neuropathology","volume":"18","author":"Braun","year":"2023","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbih.2024.100826_bib11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41580-020-00322-w","article-title":"Diversity and versatility of p38 kinase signalling in health and disease","volume":"22","author":"Canovas","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbih.2024.100826_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1172\/JCI77888","article-title":"Long-term potentiation decay and memory loss are mediated by AMPAR endocytosis","volume":"125","author":"Dong","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"293","key":"10.1016\/j.bbih.2024.100826_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/01621459.1961.10482090","article-title":"Multiple comparisons among means","volume":"56","author":"Dunn","year":"1961","journal-title":"J. Am. Stat. Assoc."},{"issue":"272","key":"10.1016\/j.bbih.2024.100826_bib14","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1080\/01621459.1955.10501294","article-title":"Multiple comparison procedure for comparing several treatments with a control","volume":"50","author":"Dunnett","year":"1955","journal-title":"J. Am. Stat. Assoc."},{"issue":"1","key":"10.1016\/j.bbih.2024.100826_bib15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/imr.12896","article-title":"The role of innate immunity in Alzheimer's disease","volume":"297","author":"Ennerfelt","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbih.2024.100826_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1742-2094-8-26","article-title":"Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease","volume":"8","author":"Grammas","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.bbih.2024.100826_bib17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.bbih.2024.100826_bib18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.bbih.2024.100826_bib19","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","article-title":"Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration","volume":"68","author":"Hoover","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.bbih.2024.100826_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3300327","article-title":"p38 MAPK endogenous inhibition improves neurological deficits in global cerebral ischemia\/reperfusion mice","volume":"2022","author":"Hou","year":"2022","journal-title":"Neural Plast."},{"issue":"13","key":"10.1016\/j.bbih.2024.100826_bib21","doi-asserted-by":"crossref","first-page":"12286","DOI":"10.1074\/jbc.M312868200","article-title":"Rap1-induced p38 mitogen-activated protein kinase activation facilitates AMPA receptor trafficking via the GDI.Rab5 complex. Potential role in (S)-3,5-dihydroxyphenylglycene-induced long term depression","volume":"279","author":"Huang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbih.2024.100826_bib22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fnmol.2017.00446","article-title":"AMPA receptor trafficking in natural and pathological aging","volume":"10","author":"Jurado","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.bbih.2024.100826_bib23","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbadis.2015.12.023","article-title":"Vascular contributions to cognitive impairment, clinical Alzheimer's disease, and dementia in older persons","volume":"1862","author":"Kapasi","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.bbih.2024.100826_bib24","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1177\/0271678X16662043","article-title":"Inflammasomes link vascular disease with neuroinflammation and brain disorders","volume":"36","author":"Lenart","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"10.1016\/j.bbih.2024.100826_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13195-016-0221-y","article-title":"Selective suppression of the alpha isoform of p38 MAPK rescues late-stage tau pathology","volume":"8","author":"Maphis","year":"2016","journal-title":"Alzheimer's Res. Ther."},{"issue":"49","key":"10.1016\/j.bbih.2024.100826_bib26","doi-asserted-by":"crossref","DOI":"10.3791\/2330","article-title":"Preparation of acute hippocampal slices from rats and transgenic mice for the study of synaptic alterations during aging and amyloid pathology","author":"Mathis","year":"2011","journal-title":"J. Vis. Exp."},{"issue":"40","key":"10.1016\/j.bbih.2024.100826_bib28","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"issue":"13","key":"10.1016\/j.bbih.2024.100826_bib29","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.febslet.2006.04.088","article-title":"Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia","volume":"580","author":"Obeid","year":"2006","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.bbih.2024.100826_bib27","article-title":"Visuo-spatial learning and memory impairments in the 5xFAD mouse model of Alzheimer\u2019s disease: effects of age, sex, albinism, and motor impairments","volume":"21","author":"O\u2019Leary","year":"2022","journal-title":"Genes Brain Behav"},{"issue":"1","key":"10.1016\/j.bbih.2024.100826_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13195-021-00843-2","article-title":"A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease","volume":"13","author":"Prins","year":"2021","journal-title":"Alzheimer's Res. Ther."},{"issue":"6","key":"10.1016\/j.bbih.2024.100826_bib31","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra","volume":"30","author":"Provencher","year":"1993","journal-title":"Magn. Reson. Med."},{"issue":"5","key":"10.1016\/j.bbih.2024.100826_bib32","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1189\/jlb.2AB0116-009RR","article-title":"Anti-inflammatory roles of p38alpha MAPK in macrophages are context dependent and require IL-10","volume":"102","author":"Raza","year":"2017","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.bbih.2024.100826_bib33","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/acschemneuro.5b00002","article-title":"Targeting human central nervous system protein kinases: an isoform selective p38alphaMAPK inhibitor that attenuates disease progression in Alzheimer's disease mouse models","volume":"6","author":"Roy","year":"2015","journal-title":"ACS Chem. Neurosci."},{"issue":"11","key":"10.1016\/j.bbih.2024.100826_bib34","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1021\/acs.jmedchem.9b00058","article-title":"A selective and brain penetrant p38alphaMAPK inhibitor candidate for neurologic and neuropsychiatric disorders that attenuates neuroinflammation and cognitive dysfunction","volume":"62","author":"Roy","year":"2019","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bbih.2024.100826_bib35","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/acn3.549","article-title":"An exploratory clinical study of p38alpha kinase inhibition in Alzheimer's disease","volume":"5","author":"Scheltens","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"10.1016\/j.bbih.2024.100826_bib36","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3233\/JAD-210523","article-title":"Sex differences in behavior and molecular pathology in the 5XFAD model","volume":"85","author":"Sil","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.bbih.2024.100826_bib37","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/jcbfm.2013.1","article-title":"Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation","volume":"33","author":"Sudduth","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"10.1016\/j.bbih.2024.100826_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/alzrt262","article-title":"beta-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP\/PS1 transgenic mice","volume":"6","author":"Sudduth","year":"2014","journal-title":"Alzheimer's Res. Ther."},{"issue":"1","key":"10.1016\/j.bbih.2024.100826_bib39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41398-022-02024-7","article-title":"Neuronal hyperexcitability in Alzheimer's disease: what are the drivers behind this aberrant phenotype?","volume":"12","author":"Targa Dias Anastacio","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"Pt 9","key":"10.1016\/j.bbih.2024.100826_bib40","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/brain\/awt188","article-title":"Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre","volume":"136","author":"Toledo","year":"2013","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.bbih.2024.100826_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.trci.2016.05.001","article-title":"The roles of inflammation and immune mechanisms in Alzheimer's disease","volume":"2","author":"Van Eldik","year":"2016","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"10.1016\/j.bbih.2024.100826_bib42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","article-title":"The role of pathological tau in synaptic dysfunction in Alzheimer's diseases","volume":"10","author":"Wu","year":"2021","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.bbih.2024.100826_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12974-017-0845-2","article-title":"Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes","volume":"14","author":"Zhou","year":"2017","journal-title":"J. Neuroinflammation"}],"container-title":["Brain, Behavior, &amp; Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354624001042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354624001042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:10:26Z","timestamp":1778919026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666354624001042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":43,"alternative-id":["S2666354624001042"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2024.100826","relation":{},"ISSN":["2666-3546"],"issn-type":[{"value":"2666-3546","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A small molecule p38\u03b1 MAPK inhibitor, MW150, attenuates behavioral deficits and neuronal dysfunction in a mouse model of mixed amyloid and vascular pathologies","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2024.100826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100826"}}